Two Sigma Investments, LP Syndax Pharmaceuticals Inc Transaction History

Two Sigma Investments, LP

$42.3 Billion
Q3 2024

A detailed history of Two Sigma Investments, LP transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Two Sigma Investments, LP holds 886,494 shares of SNDX stock, worth $11.6 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

886,494

Previous 930,947 4.78%

Holding current value

$11.6 Million

Previous $19.1 Million 10.71%

% of portfolio

0.04%

Previous 0.05%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$17.93 - $24.81 $797,042 - $1.1 Million	-44,453 Reduced 4.78%	886,494 $17.1 Million
Q2 2024 Aug 14, 2024	BUY	$18.82 - $23.79 $4 Million - $5.05 Million	212,395 Added 29.56%	930,947 $19.1 Million
Q1 2024 May 15, 2024	BUY	$19.71 - $24.57 $3.6 Million - $4.49 Million	182,614 Added 34.07%	718,552 $17.1 Million
Q4 2023 Feb 14, 2024	BUY	$11.39 - $21.67 $1.19 Million - $2.26 Million	104,373 Added 24.18%	535,938 $11.6 Million
Q3 2023 Nov 14, 2023	BUY	$14.52 - $21.77 $6.27 Million - $9.4 Million	431,565 New	431,565 $6.27 Million
Q1 2023 May 15, 2023	BUY	$20.66 - $28.98 $1.43 Million - $2 Million	69,169 New	69,169 $1.46 Million
Q2 2022 Aug 15, 2022	SELL	$13.64 - $19.48 $1.77 Million - $2.52 Million	-129,584 Reduced 57.84%	94,474 $1.82 Million
Q1 2022 May 16, 2022	SELL	$14.84 - $22.15 $1.46 Million - $2.19 Million	-98,662 Reduced 30.57%	224,058 $3.89 Million
Q4 2021 Feb 14, 2022	BUY	$15.23 - $22.47 $3.24 Million - $4.78 Million	212,740 Added 193.44%	322,720 $7.06 Million
Q3 2021 Nov 15, 2021	SELL	$13.87 - $19.8 $32,719 - $46,708	-2,359 Reduced 2.1%	109,980 $2.1 Million
Q2 2021 Aug 16, 2021	SELL	$13.42 - $25.18 $1.73 Million - $3.25 Million	-129,075 Reduced 53.47%	112,339 $1.93 Million
Q1 2021 May 17, 2021	SELL	$19.28 - $24.59 $6.81 Million - $8.69 Million	-353,457 Reduced 59.42%	241,414 $5.4 Million
Q4 2020 Feb 16, 2021	BUY	$15.1 - $26.44 $5.56 Million - $9.73 Million	368,182 Added 162.42%	594,871 $13.2 Million
Q3 2020 Nov 16, 2020	SELL	$13.39 - $17.48 $1.72 Million - $2.24 Million	-128,122 Reduced 36.11%	226,689 $3.35 Million
Q2 2020 Aug 14, 2020	BUY	$8.94 - $20.98 $2.59 Million - $6.08 Million	290,006 Added 447.51%	354,811 $5.26 Million
Q1 2020 May 15, 2020	BUY	$6.65 - $12.03 $57,263 - $103,590	8,611 Added 15.32%	64,805 $711,000
Q4 2019 Feb 14, 2020	BUY	$5.43 - $9.22 $208,832 - $354,591	38,459 Added 216.85%	56,194 $493,000
Q3 2019 Nov 14, 2019	BUY	$7.47 - $10.76 $132,480 - $190,828	17,735 New	17,735 $132,000
Q1 2019 May 15, 2019	SELL	$4.26 - $6.86 $57,454 - $92,520	-13,487 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$3.6 - $8.42 $34,480 - $80,646	-9,578 Reduced 41.53%	13,487 $60,000
Q3 2018 Nov 14, 2018	BUY	$6.33 - $8.08 $146,001 - $186,365	23,065 New	23,065 $186,000
Q1 2018 May 15, 2018	SELL	$8.71 - $14.82 $269,400 - $458,382	-30,930 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$7.8 - $12.94 $241,254 - $400,234	30,930	30,930 $271,000

Others Institutions Holding SNDX

# of Institutions

228

Shares Held

88.4M

Call Options Held

1.01M

Put Options Held

692K

View Full List

About Syndax Pharmaceuticals Inc

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $740M
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

More about SNDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account

Two Sigma Investments, LP Syndax Pharmaceuticals Inc Transaction History